Starling Oncology, Inc. (STLN)
$5.17+0.78%Close
SELLRECOVERY · day 1
Key stats
- Avg volume
- 1.1M
- Beta
- 0.00
- 1W
- +4.44%
- 1M
- -4.96%
- 3M
- +26.72%
- YTD
- +40.87%
- vs SPY 1W
- +0.33%
- vs SPY 1M
- -7.63%
- vs SPY 3M
- +19.29%
- vs SPY YTD
- +27.97%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- KODBUYKodiak Sciences Inc.RECOVERYQ 38$42.89+7.68%
- BNRBUYBurning Rock Biotech LimitedCRISISQ -15$8.97+1.47%
- RNTXSELLRein Therapeutics Inc.CRISISQ -11$0.76+1.33%
- STROSELLSutro Biopharma, Inc.CRISISQ -5$25.67+2.27%
- IMRNSELLImmuron LimitedCRISISQ 4$1.08+1.89%
- KYTXSELLKyverna Therapeutics, Inc.CRISISQ -17$7.78+3.60%
- ANGOBUYAngioDynamics, Inc.BULLQ 5$15.19+0.13%
- NUVLBUYNuvalent, Inc.BULLQ 42$123.96+0.00%
- CRDLBUYCardiol Therapeutics Inc.RECOVERYQ 2$1.36+3.82%
- BCYCSELLBicycle Therapeutics plcCRISISQ -3$3.94+1.81%
- NCNASELLNuCana plcRECOVERYQ -21$1.39+2.96%
- ENTXBUYEntera Bio Ltd.CRISISQ 9$2.87-3.04%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 4
- VALUE
- 0
- GROWTH
- 16
- GARP
- 18
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC-
REV YoY41.2%
ROE-
EPS YoY-
ROA-12.3%
---
[VALUATION]
P/E TTM-
P/E FWD-
SECTOR PE23.64
INDUSTRY PE46.52
P/B-
P/FCF-
EV/EBITDA-
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO-
ND/EBITDA-
BETA0.00
NET INCOME (TTM) < 0
Company news
Loading headlines…